According to China Pharmaceutical's announcement, its wholly-owned subsidiaries Hainan GM Sanyo Pharmaceutical Co., Ltd. and Hainan Kangli Pharmaceutical Co., Ltd. have each received a “Notice on Tax Matters” from the First Taxation Branch of the Haikou Taxation Bureau of the State Administration of Taxation requesting supplementary payment of relevant taxes. Sanyo Pharmaceutical is required to pay additional taxes of 21.4862 million yuan, with late payment fees of about 10.742,900 yuan; Kangli Pharmaceutical is required to pay additional taxes of 21.2826 million yuan, and late payment of about 11.761 million yuan. The total amount of additional tax and late payment fees is approximately $65.217,800.

According to China Pharmaceutical's announcement, its wholly-owned subsidiaries Hainan GM Sanyo Pharmaceutical Co., Ltd. and Hainan Kangli Pharmaceutical Co., Ltd. have each received a “Notice on Tax Matters” from the First Taxation Branch of the Haikou Taxation Bureau of the State Administration of Taxation requesting supplementary payment of relevant taxes. Sanyo Pharmaceutical is required to pay additional taxes of 21.4862 million yuan, with late payment fees of about 10.742,900 yuan; Kangli Pharmaceutical is required to pay additional taxes of 21.2826 million yuan, and late payment of about 11.761 million yuan. The total amount of additional tax and late payment fees is approximately $65.217,800.